Page URL: https://www.bionews.org.uk/page_94285

Stem cell and gene therapy heart attack therapy trials begin

9 September 2013
Appeared in BioNews 721

The first patients from two separate ongoing studies have been treated using gene and stem cell therapies to repair damage caused by heart attacks.

Canadian researchers are trialling a technique that uses genetically enhanced stem cells. Taking a blood sample from patients soon after a heart attack, they can harvest cells known as endothelial progenitor cells that have the ability to form new blood vessels. These are then injected into the heart, where it is hoped they will help muscle to regenerate.

However, cells from patients with heart disease may not be as effective at forming new tissue, so the team plans to add a gene that stimulates blood vessel growth and improves tissue healing, known as endothelial nitric oxide synthase.

'Our strategy is to rejuvenate these stem cells by providing extra copies of a gene that is essential for their regenerative activity, so that they better stimulate heart repair, reduce scar tissue and restore the heart's ability to pump blood efficiently - in other words to help the heart fix itself', said Dr Duncan Stewart, lead investigator of the trial at the Ottawa Hospital Research Institute.

The first patient to be treated on the Canadian trial is 68-year-old Harriet Garrow, who suffered a heart attack in July 2013. Garrow received one of three treatments as part of the randomised double-blind trial – either normal stem cells, genetically enhanced stem cells, or a placebo injection of her own blood plasma. She told the Huffington Post: 'I feel really good. I get better every day, stronger'.

In the UK, another trial reported in BioNews 703 has begun testing in patients. Researchers at Imperial College London will deliver the SERCA2 gene into people with heart failure using a carrier virus. The gene expresses a protein involved in calcium signalling, which allows the heart to pump more effectively.

Dr Alexander Lyon, consultant cardiologist at Royal Brompton Hospital, told the BBC: 'Importantly, early trials suggest the treatment is safe. But we need this large study before we can be sure the gene therapy really works. If we could find an effective treatment, that would be very exciting'.

The Canadian trial will last a further two years, with the trial in the UK due to end in three years.

SOURCES & REFERENCES
First patient treated in groundbreaking stem cell therapy trial for heart attack
Ottawa Hospital Research Institute (press release) |  5 September 2013
Gene-Enhanced Stem Cells May Be Able To Repair Heart Attack Damage
Huffington Post |  5 September 2013
Heart gene therapy trial begins
BBC News |  5 September 2013
Study looks at stem cells’ impact on heart attack victims
The Globe and Mail |  5 September 2013
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
18 August 2014 - by Isobel Steer 
A gene therapy trial has been launched to help people with advanced heart failure who must constantly carry a bulky battery to power an artificial heart pump....
16 June 2014 - by Dr Kimberley Bryon-Dodd 
Genes linked to cholesterol levels have been successfully edited in mice who received a single injection, thereby reducing their risk of heart disease, according to a study...
12 May 2014 - by Dr Greg Ball 
Two major reviews of clinical trials using stem cells to treat advanced heart disease have found a positive effect of the stem cell treatment, but caution against overstating this effect until more trials are carried out...
6 May 2014 - by Dr Rachael Panizzo 
Heart cells derived from human embryonic stem cells are capable of regenerating damaged heart muscle in primates, a US study has found...
3 February 2014 - by Dr Lanay Griessner 
Stem cells have been created from mouse blood cells using a simple and quick method described as 'remarkable' by experts...
18 November 2013 - by Siobhan Chan 
Heart failure can be reversed using gene therapy, with the effect being amplified when two genes are used together, a study in pigs has found...
11 November 2013 - by Dr Naqash Raja 
The Children's Hospital of Philadelphia has invested US $50 million in a biotech start-up in an effort to commercialise gene therapy...
16 September 2013 - by Siobhan Chan 
One comprehensive genetic database is needed for the prevention of deaths from cardiac disease to be a reality, says a cardiology expert...
16 September 2013 - by James Brooks 
For the first time living tissue in mice has been induced into an embryonic state without any intervening preparation in the lab...
27 August 2013 - by Lanay Tierney 
Researchers have concocted a 'gene cocktail' that may help to turn scar tissue into functioning cardiac cells after a heart attack...
19 August 2013 - by Dr Katie Howe 
A mouse heart was able to contract again after its own cells were removed and replaced with human stem cells, a study in Nature Communications reports...
7 May 2013 - by Siobhan Chan 
Gene therapy will be used to treat heart failure for the first time in the UK, in clinical trials being launched by the British Heart Foundation...
22 April 2013 - by Emma Stoye 
Researchers have identified a gene that regulates the regeneration of adult heart cells...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.